{Reference Type}: Journal Article
{Title}: Plasma Instead of Serum Avoids Critical Confounding of Clinical Metabolomics Studies by Platelets.
{Author}: Hagn G;Meier-Menches SM;Plessl-Walder G;Mitra G;Mohr T;Preindl K;Schlatter A;Schmidl D;Gerner C;Garhöfer G;Bileck A;
{Journal}: J Proteome Res
{Volume}: 23
{Issue}: 8
{Year}: 2024 Aug 2
{Factor}: 5.37
{DOI}: 10.1021/acs.jproteome.3c00761
{Abstract}: Metabolomics is an emerging and powerful bioanalytical method supporting clinical investigations. Serum and plasma are commonly used without rational prioritization. Serum is collected after blood coagulation, a complex biochemical process involving active platelet metabolism. This may affect the metabolome and increase the variance, as platelet counts and function may vary substantially in individuals. A multiomics approach systematically investigating the suitability of serum and plasma for clinical studies demonstrated that metabolites correlated well (n = 461, R2 = 0.991), whereas lipid mediators (n = 83, R2 = 0.906) and proteins (n = 322, R2 = 0.860) differed substantially between specimen. Independently, analysis of platelet releasates identified most biomolecules significantly enriched in serum compared to plasma. A prospective, randomized, controlled parallel group metabolomics trial with acetylsalicylic acid administered for 7 days demonstrated that the apparent drug effects significantly differ depending on the analyzed specimen. Only serum analyses of healthy individuals suggested a significant downregulation of TXB2 and 12-HETE, which were specifically formed during coagulation in vitro. Plasma analyses reliably identified acetylsalicylic acid effects on metabolites and lipids occurring in vivo such as an increase in serotonin, 15-deoxy-PGJ2 and sphingosine-1-phosphate and a decrease in polyunsaturated fatty acids. The present data suggest that plasma should be preferred above serum for clinical metabolomics studies as the serum metabolome may be substantially confounded by platelets.